Epithelial Cytokines and Chronic Airway Diseases

Prefer to participate in person? Register for our live program at ExchangeCME.com/CRSwNPSanDiegoLive.

This program is not certified for continuing education credit. The content provided and opinions expressed are those of the sponsor and/or presenter(s) and are not necessarily those of the AAAAI or WAO.

Target Audience

The educational design of this activity addresses the needs of clinical immunologist/allergist and ear, nose, and throat (ENT) specialists, as well as pulmonologists, who manage patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

Program Overview

Chronic inflammatory diseases of the upper and lower airways, especially CRSwNP, have been tied to significant risks and burdens for affected patients. Although biologic therapies that target overactive cytokine signaling are available, newer therapies are emerging, with targets upstream in the pathogenic cascade to improve efficacy across both type 2 (T2)-high and T2-low profiles. Join us for this engaging Expert Roundtable where faculty will present a 3D animation of pathophysiologic processes in the upper airway epithelium and you can gain multidisciplinary insights on burdens and management challenges associated with CSRwNP and learn about current and emerging treatment options.

Educational Objectives

After completing this activity, the participant should be better able to:

1. Describe the contributions of epithelial cytokine signaling to the pathogenesis of CRSwNP
2. Evaluate patients with CRSwNP for symptom burden, disease phenotype, and effects on health-related quality of life
3. Discuss the clinical profiles of current and emerging biologic therapies, including anti–thymic stromal lymphopoietin agents, for patients with CRSwNP
4. Tailor CRSwNP treatment regimens based on patient symptoms, endotype, treatment goals, and comorbidities

Agenda

6:30 pm–7:00 pm             Registration/Dinner
7:00 pm–7:10 pm             Preactivity Questionnaire and Faculty Introductions
7:10 pm–7:45 pm             Epithelial Pathophysiology in Upper Airways
7:45 pm–7:55 pm             Consequences and Burdens of CRSwNP
7:55 pm–8:15 pm             Addressing Challenges in the Biologic-Based Management of CRSwNP
8:15 pm–8:30 pm             Postactivity Questionnaire and Q&A Session

Disclosures of Conflicts of Interest

Integritas adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Integritas are required to disclose all financial relationships with any ineligible company within the past 24 months to Integritas. All financial relationships reported are identified as relevant and mitigated by Integritas in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Integritas to assure objectivity and that the activity is free of commercial bias. 

All relevant financial relationships have been mitigated.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integritas does not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Americans With Disabilities Act

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc.). Please contact us prior to the live event at info@exchangecme.com.

Integritas Contact Information

For questions about this activity, please contact us at info@exchangecme.com.